Skip to main content
OpenTrials
Completed

NCT Number: NCT00609908

The Technique of Skin Stretching for Acute Burn Treatment and Scar Reconstruction

Objective:

A randomized controlled trial is performed to evaluate the clinical effectiveness of the skin stretching technique for two categories:

1. acute burn wounds: wound closure by means of skin stretching should lead to a significant reduction of scar surface area in comparison to the standard technique, the split skin grafting; 2. scar reconstructions: wound closure by means of skin stretching during one operative procedure should lead to a comparable scar surface in comparison to the multiple procedures techniques such as serial excision.

Study design:

Skin stretching will be compared to split skin grafting and should result in burn wound closure with significantly smaller scars. Also, a comparison will be made between the technique of serial excision versus skin stretching for scar reconstructions.

Scar evaluation three and twelve months after surgery will include the following parameters:

* surface area; * Patient and Observer Scar Assessment Scale (POSAS); * elasticity; * vascularization and pigmentation; * thickness; * dermal architecture.

After 12 months adults will undergo a biopsy of the scar under local anesthesia. The experimental group, treated with the skin stretcher will undergo one extra biopsy of the formerly stretched skin.

Intervention:

At the start of the operation will be determined by randomization if skin stretching or split skin grafting (acute burn wounds) or serial excision (scar reconstruction category) will be performed.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Red Cross Hospital

Beverwijk, Netherlands

About this study

Eligibility criteria:

Inclusion:

  • Acute Burn wounds or scar reconstructions that require surgical treatment; 2. Sufficient healthy skin at (at least) one edge of the wound/scar must be available for the stretching procedure.
  • Age >= 18 years

Exclusion:

  • language barrier;
  • known history of keloid formation;
  • systemic diseases: Diabetes Mellitus, immunodeficiency, arterial insufficiency;
  • local or systemic application of corticosteroids;
  • psychiatric diseases leading to study bias (e.g. automutilation);
  • skin diseases that lead to collagen and/or elastin abnormalities such as Ehlers Danlos;
  • radiated skin;
  • wound located at extremities, exceeding >33% of circumference (acute burn category);

Primary study parameters/outcome of the study:

The primary study parameter is the surface area of the scar after 12 months

Secondary study parameters/outcome of the study (if applicable):

All scars will also be subjected to the scar evaluation protocol after 3 and 12 months by an independent observer for the evaluation of the:

  • patient and observer scar assessment scale (POSAS);
  • scar elasticity (Cutometer);
  • scar vascularisation & pigmentation (DermaSpectrometer);
  • scar thickness (histopathology, only after 12 months).

Punch biopsies are taken for morphometry of dermal architecture (Fourier analysis). During surgery one biopsy is obtained of the normal skin. In the experimental group an additional biopsy is obtained at the end of the stretching procedure in order to be able to compare structure of the dermal matrix and orientation of the collagen fibers.

After 1 year, one biopsy is taken from the scar. The experimental group will undergo one additional biopsy of the formerly stretched skin.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Acute Burn wounds or scar reconstructions that require surgical treatment;
  • Sufficient healthy skin at (at least) one edge of the wound/scar must be available for the stretching procedure;
  • Age >= 18 years.

Exclusion criteria

  • Language barrier;
  • Known history of keloid formation;
  • Systemic diseases: Diabetes Mellitus, immunodeficiency, arterial insufficiency;
  • Local or systemic application of corticosteroids;
  • Psychiatric diseases leading to study bias (e.g. automutilation);
  • Skin diseases that lead to collagen and/or elastin abnormalities such as Ehlers Danlos;
  • Radiated skin;
  • Wound located at extremities, exceeding >33% of circumference (acute burn category).

Treatment and study plan

Split skin graft

Procedure

After wound bed preparation the skin defect is covered with a skin transplant (split skin graft)

skin stretching device

Procedure

after woundbed preparation the wound is primarily closed by aid of the skin stretching device

serial excision

Procedure

as much scar as possible is excised, whereafter the wound is closed

Primary outcomes

  1. the surface area of the scar after 12 months

    Time frame: 3 and 12 months after surgery

Secondary outcomes

  1. scar evaluation protocol: - patient and observer scar assessment scale (POSAS); - scar elasticity (Cutometer); - scar vascularization & pigmentation (DermaSpectrometer); - scar thickness

    Time frame: 3 and 12 months after surgery

Sponsors and collaborators

Lead sponsor

Association of Dutch Burn Centres

Other

Registry information

Official study title

The Technique of Skin Stretching for Acute Burn Treatment and Scar Reconstruction: Clinical Applications and Working Mechanisms.

Important dates

Study start
2007
Primary completion
2011
Study completion
2011
First posted
Feb 7, 2008
Registry last updated
Jun 26, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.